Financhill
Back

Regulus Therapeutics Quote, Financials, Valuation and Earnings

Sell
35

RGLS
Regulus Therapeutics

Last Price:
1.99
Seasonality Move:
-26.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Regulus Therapeutics Price Quote

$1.99
-0.01 (-0.5%)
(Updated: May 18, 2024 at 5:52 AM ET)

Regulus Therapeutics Key Stats

Sell
35
Regulus Therapeutics (RGLS) is a Sell

Day range:
$1.95 - $2.10
52-week range:
$1.08 - $3.79
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.22%

Volume:
263.3K
Avg. volume:
375.4K
1-year change:
22.7%
Market cap:
$130.9M
Revenue:
$0
EPS:
$-1.45

How Much Does Regulus Therapeutics Make?

Data Unavailable

Is Regulus Therapeutics Growing As A Company?

Data Unavailable

Regulus Therapeutics Stock Price Performance

What Is Regulus Therapeutics 52-Week High & Low?

Regulus Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Regulus Therapeutics?

Is Regulus Therapeutics Cash Flow Positive?

  • What Is RGLS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$27.4M
  • What Is Regulus Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $105.7M
  • What Is Regulus Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$79.1M

Regulus Therapeutics Return On Invested Capital

Data Unavailable

Regulus Therapeutics Earnings Date & Stock Price

Regulus Therapeutics Competitors

Regulus Therapeutics Dividend Yield

Data Unavailable

Regulus Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -11.54%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 7.25
Upside from Last Price: 262.5%

Major Shareholders

  • How many RGLS shares are owned by institutional investors?
    58.6M RGLS shares are owned by institutional investors
  • How many RGLS shares are owned by insiders?
    1.5M RGLS shares are owned by insiders